This study is looking at the effect of the dietary supplement Nicotinamide mononucleotide (NMN) on key cardiovascular and metabolic functions, specifically those that are important risk factors for diabetes and cardiovascular disease.
The goal of this proposal is to determine whether the beneficial effects of NMN on metabolic function observed in rodents applies to people.